4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile

C202H110N30O15S2 — CID 160995645

About 4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile

4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile (PubChem CID 160995645) has the molecular formula C202H110N30O15S2 and a molecular weight of 3261.43 g/mol. Its IUPAC name is 4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile.

Molecular Properties

• Compound Name: 4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile
• PubChem CID: 160995645
• Molecular Formula: C202H110N30O15S2
• Molecular Weight: 3261.43 g/mol
• Exact Mass: 3258.82
• IUPAC Name: 4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile
• SMILES: N#Cc1nc2c3ccc4c5c(ccc(c(=O)n2c1C#N)c53)C(=O)N(c1cccc2ccccc12)C4=O.O=C1c2ccc3c(=O)n4c(-c5cccs5)c(-c5cccs5)nc4c4ccc(c2c34)C(=O)N1c1ccc2ccccc2c1.O=C1c2ccc3c(=O)n4c(Cc5nc6ccccc6n5-c5ccccc5)c(-c5nc6ccccc6n5-c5ccccc5)nc4c4ccc(c2c34)C(=O)N1c1cccc2ccccc12.O=C1c2ccc3c(=O)n4c(Cc5nc6ccccc6n5-c5ccccc5)c(-c5nc6ccccc6n5-c5ccccc5)nc4c4ccc(c2c34)C(=O)N1c1nc2ccccc2n1-c1ccccc1.O=C1c2ccc3c4c(ccc(c24)C(=O)N1c1ccccn1)C(O)n1c-3nc(-c2ccccn2)c1-c1ccccn1
• InChI: InChI=1S/C56H33N9O3.C53H31N7O3.C34H17N3O3S2.C31H18N6O3.C28H11N5O3/c66-53-37-30-31-39-49-38(54(67)65(55(39)68)56-59-42-24-12-15-27-45(42)63(56)35-20-8-3-9-21-35)29-28-36(48(37)49)51-60-50(52-58-41-23-11-14-26-44(41)62(52)34-18-6-2-7-19-34)46(64(51)53)32-47-57-40-22-10-13-25-43(40)61(47)33-16-4-1-5-17-33;61-51-36-28-29-38-47-37(52(62)60(53(38)63)41-25-13-15-31-14-7-8-20-34(31)41)27-26-35(46(36)47)49-56-48(50-55-40-22-10-12-24-43(40)58(50)33-18-5-2-6-19-33)44(59(49)51)30-45-54-39-21-9-11-23-42(39)57(45)32-16-3-1-4-17-32;38-32-23-12-11-21-27-22(34(40)37-30(26-8-4-16-42-26)29(35-31(21)37)25-7-3-15-41-25)13-14-24(28(23)27)33(39)36(32)20-10-9-18-5-1-2-6-19(18)17-20;38-29-19-11-10-17-24-18(12-13-20(25(19)24)30(39)36(29)23-9-3-6-16-34-23)31(40)37-27(22-8-2-5-15-33-22)26(35-28(17)37)21-7-1-4-14-32-21;29-12-20-22(13-30)32-25(31-20)16-8-9-18-24-19(11-10-17(23(16)24)26(32)34)28(36)33(27(18)35)21-7-3-5-14-4-1-2-6-15(14)21/h1-31H,32H2;1-29H,30H2;1-17H;1-16,31,40H;1-11H
• InChIKey: TVFCVQWTLKEEJM-UHFFFAOYSA-N
• XLogP: 37.70
• TPSA: 537.78 Ų
• H-Bond Donors: 1
• H-Bond Acceptors: 42
• Rotatable Bonds: 20
• Heavy Atoms: 249
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3261.43
LogP ≤ 5	37.70
H-Bond Donors ≤ 5	1
H-Bond Acceptors ≤ 10	42

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile?

The IUPAC name of 4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile (CID 160995645) is 4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile.

What is the SMILES notation for 4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile?

The canonical SMILES for 4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile is N#Cc1nc2c3ccc4c5c(ccc(c(=O)n2c1C#N)c53)C(=O)N(c1cccc2ccccc12)C4=O.O=C1c2ccc3c(=O)n4c(-c5cccs5)c(-c5cccs5)nc4c4ccc(c2c34)C(=O)N1c1ccc2ccccc2c1.O=C1c2ccc3c(=O)n4c(Cc5nc6ccccc6n5-c5ccccc5)c(-c5nc6ccccc6n5-c5ccccc5)nc4c4ccc(c2c34)C(=O)N1c1cccc2ccccc12.O=C1c2ccc3c(=O)n4c(Cc5nc6ccccc6n5-c5ccccc5)c(-c5nc6ccccc6n5-c5ccccc5)nc4c4ccc(c2c34)C(=O)N1c1nc2ccccc2n1-c1ccccc1.O=C1c2ccc3c4c(ccc(c24)C(=O)N1c1ccccn1)C(O)n1c-3nc(-c2ccccn2)c1-c1ccccn1.

What is the InChIKey of 4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile?

The InChIKey is TVFCVQWTLKEEJM-UHFFFAOYSA-N. The full InChI is InChI=1S/C56H33N9O3.C53H31N7O3.C34H17N3O3S2.C31H18N6O3.C28H11N5O3/c66-53-37-30-31-39-49-38(54(67)65(55(39)68)56-59-42-24-12-15-27-45(42)63(56)35-20-8-3-9-21-35)29-28-36(48(37)49)51-60-50(52-58-41-23-11-14-26-44(41)62(52)34-18-6-2-7-19-34)46(64(51)53)32-47-57-40-22-10-13-25-43(40)61(47)33-16-4-1-5-17-33;61-51-36-28-29-38-47-37(52(62)60(53(38)63)41-25-13-15-31-14-7-8-20-34(31)41)27-26-35(46(36)47)49-56-48(50-55-40-22-10-12-24-43(40)58(50)33-18-5-2-6-19-33)44(59(49)51)30-45-54-39-21-9-11-23-42(39)57(45)32-16-3-1-4-17-32;38-32-23-12-11-21-27-22(34(40)37-30(26-8-4-16-42-26)29(35-31(21)37)25-7-3-15-41-25)13-14-24(28(23)27)33(39)36(32)20-10-9-18-5-1-2-6-19(18)17-20;38-29-19-11-10-17-24-18(12-13-20(25(19)24)30(39)36(29)23-9-3-6-16-34-23)31(40)37-27(22-8-2-5-15-33-22)26(35-28(17)37)21-7-1-4-14-32-21;29-12-20-22(13-30)32-25(31-20)16-8-9-18-24-19(11-10-17(23(16)24)26(32)34)28(36)33(27(18)35)21-7-3-5-14-4-1-2-6-15(14)21/h1-31H,32H2;1-29H,30H2;1-17H;1-16,31,40H;1-11H.

What are the key properties of 4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile?

4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile has a molecular weight of 3261.43 g/mol, XLogP of 37.70, 20 rotatable bonds, 1 hydrogen bond donors, and 42 hydrogen bond acceptors.

Where does this data come from?

All data for 4,13-bis(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;7-hydroxy-4,5,13-tripyridin-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-12,14-dione;13-naphthalen-2-yl-4,5-dithiophen-2-yl-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-4-(1-phenylbenzimidazol-2-yl)-5-[(1-phenylbenzimidazol-2-yl)methyl]-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-7,12,14-trione;13-naphthalen-1-yl-7,12,14-trioxo-3,6,13-triazapentacyclo[9.6.2.02,6.08,18.015,19]nonadeca-1(18),2,4,8,10,15(19),16-heptaene-4,5-dicarbonitrile is sourced from PubChem (CID 160995645), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).